Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Strang

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Anticancer Research|November 1, 1991
Prognostic indices in endometrial adenocarcinoma stages I and II. A study based on clinical, histopathological and flow cytometric variablesG Wagenius, P Strang, R Bergström, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2000
Brain tumours in Sweden 1996: care and costsP Blomqvist, J Lycke, P Strang, et al.
Anticancer Research|January 1, 1990
Influence of oestrogen on growth of endometrial carcinomaK Boman, P Strang, T Bäckström, et al.
Anticancer Research|July 1, 1989
Age, menopausal status and DNA-content in endometrial adenocarcinomaP Strang, U Stendahl, B Tribukait, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1991
Prognostic significance of proliferation in endometrial adenocarcinomas: a multivariate analysis of clinical and flow cytometric variablesU Stendahl, P Strang, G Wagenius, et al.
Gynecologic Oncology|October 1, 1991
Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patientsP Strang, U Stendahl, R Bergström, et al.
Anticancer Research|July 25, 1998
Pain figures are unsuitable for determination of palliative radiotherapy portals in patients with hormone refractory prostatic cancerK M Kälkner, J E Westlin, S Nilsson, et al.
Cancer|November 1, 1996
A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fractionB Nordström, P Strang, R Bergström, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 1, 1996
Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications?B Nordström, P Strang, A Lindgren, et al.
Anticancer Research|March 1, 1996
Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expressionB Nordström, P Strang, A Lindgren, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Anticancer Research|November 1, 1991
Prognostic indices in endometrial adenocarcinoma stages I and II. A study based on clinical, histopathological and flow cytometric variablesG Wagenius, P Strang, R Bergström, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2000
Brain tumours in Sweden 1996: care and costsP Blomqvist, J Lycke, P Strang, et al.
Anticancer Research|January 1, 1990
Influence of oestrogen on growth of endometrial carcinomaK Boman, P Strang, T Bäckström, et al.
Anticancer Research|July 1, 1989
Age, menopausal status and DNA-content in endometrial adenocarcinomaP Strang, U Stendahl, B Tribukait, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1991
Prognostic significance of proliferation in endometrial adenocarcinomas: a multivariate analysis of clinical and flow cytometric variablesU Stendahl, P Strang, G Wagenius, et al.
Gynecologic Oncology|October 1, 1991
Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patientsP Strang, U Stendahl, R Bergström, et al.
Anticancer Research|July 25, 1998
Pain figures are unsuitable for determination of palliative radiotherapy portals in patients with hormone refractory prostatic cancerK M Kälkner, J E Westlin, S Nilsson, et al.
Cancer|November 1, 1996
A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fractionB Nordström, P Strang, R Bergström, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 1, 1996
Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications?B Nordström, P Strang, A Lindgren, et al.
Anticancer Research|March 1, 1996
Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expressionB Nordström, P Strang, A Lindgren, et al.
Pageof 11